Medical Therapeutics Company Announces Positive Study Results For Cancer Treatment Technology
The Hemopurifier® has earned the prestigious designation of Breakthrough Device from the U.S. Food and Drug Administration (FDA).
Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company, has recently announced a leap forward in its mission to combat cancer and life-threatening infectious diseases. The breakthrough comes in the form of positive results from an in vitro binding study of its Hemopurifier® technology, specifically focusing on its efficacy in removing extracellular vesicles (EVs) from the plasma of cancer patients. This development signifies a beacon of hope for patients battling solid tumors who have shown stable or progressive disease during anti-PD-1 monotherapy treatment, such as Keytruda® or Opdivo®. $Aethlon Medical(AEMD.US$
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
potsy52 : Great news/ I’m upside down on this / hopefully will get a big rush Monday
104766975 potsy52: Seems disappointed, trapped
芒果哥 104766975: History is always so similar. As long as you hold it for a day, there is still hope for a day, come on